| Xu, Peng |
NCT05545137: Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection |
|
|
| Completed | 3 | 299 | RoW | Pivmecillinam hydrochloride tablets, Selexid®, Fosfomycin Tromethamine Granules, Monurol® | Benova (Tianjin) Innovative medicine Research Co., Ltd. | Uncomplicated Urinary Tract Infection | 02/24 | 02/24 | | |
GZZJU-2021NB, NCT04861584: Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects |
|
|
| Recruiting | 2 | 41 | RoW | Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin, Toripalimab | Zhujiang Hospital | Urinary Bladder Cancer | 10/26 | 04/27 | | |
NCT06341400: RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients |
|
|
| Recruiting | 1/2 | 55 | RoW | DisitamabVedotinForIicction Toripalimab, radical cystectomy | Zhujiang Hospital | Bladder Cancer, Muscle-Invasive Bladder Carcinoma | 05/26 | 05/27 | | |
BTH-DREAM-PRIDE, NCT04948749: Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial |
|
|
| Recruiting | N/A | 792 | RoW | Drug Eluting Stent implantation, Maurora ® Sirolimus Eluting Stent implantation, Aggressive medical treatment, Dual antiplatelet therapy for 6 months, Risk factor management, Risk factor and life style management, Standard medical treatment, Dual antiplatelet therapy for 3 months | Beijing Tiantan Hospital | ICAD - Intracranial Atherosclerotic Disease, ICAS - Intracranial Atherosclerosis, Drug-eluting Stent, Stroke, Drug Eluting Stents (DES), Medical Treatment | 12/26 | 12/26 | | |
NCT05067101: Comparison Capsule Sparing Cystectomy and Radical Cystoprostatectomy in Men with Bladder Cancer |
|
|
| Recruiting | N/A | 126 | RoW | Capsule Sparing Cystectomy (CSC), Conventional Radical Cystoprostatectomy (CRC) | Zhujiang Hospital | Bladder Cancer | 12/25 | 12/26 | | |
NCT04914039: Evaluation of CTA on the Assessment of Brain Death |
|
|
| Recruiting | N/A | 63 | RoW | Combination Product, NO CTA examination | Second Affiliated Hospital, School of Medicine, Zhejiang University | Brain Death | 02/22 | 02/23 | | |
